Hereditary port-wine stains, do they exist?

Lasers in Medical Science

Volumn 14, Issue 3, 1999, Pages 238-243

  Van Der Horst, C M A M ^a   Van Eijk, T G J ^b   De Borgie, C A J M ^b   Koster, P H L ^b   Struycken, P M ^b   Strackee, S D ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Family tendency; Genetics; Port wine stain; Vascular malformations

Indexed keywords

ANGIOGENESIS; ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; FEMALE; GENETIC LINKAGE; HUMAN; INHERITANCE; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; NEVUS FLAMMEUS; PEDIGREE; PRIORITY JOURNAL; SKIN HEMANGIOMA;

EID: 0032705230     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101030050090     Document Type: Article

References (31)

1. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218.
2. Osburn K, Schosser RH, Everett MA. Congenital pigmented and vascular lesions in newborn infants. J Am Acad Dermatol 1987;16:788-92.
3. Tan KI. Nevus flammeus of the nape, glabella and eyelids. Clin Pediatr 1972;11:112-18.
4. Stevenson RE, Hall JG, Goodman RM. Human malformations and related anomalies, Vol 2. Oxford Monographs on Medical Genetics New York 1993;27:990-7.
5. Mulliken JB, Young AE. Vascular birthmarks. Philadelphia: WB Saunders, 1988.
6. Burns AJ, Kaplan LC, Mulliken JB. Is there an association between hemangioma and syndrome with dysmorphic features? Pediatrics 1991;88:1257-67.
7. Gorlin RJ, Kantaputra P, Aughton D, Mulliken JB. Marked female predilection in some syndromes associated with facial hemangiomas. Am J Med Genet 1994;52:130-5.
8. Shelley WB, Livingood CS. Familial multiple nevi flammei. Arch Dermatol Syph 1949;59:343-5.
9. Selmanowicz VJ. Nevus flammeus of the forehead. J Pediatr 1968;75:755-7.
10. Shuper A, Merlob P, Garty B, Varsano I. Familial multiple naevi flammei. J Med Genet 1984;21:112-13.
11. Pasyk KA, Argenta LC, Erickson RP. Familial vascular malformations. Clin Genet 1984;26:221-7.
12. Merlob P, Reisner SH. Familial nevus flammeus of the forehead and Unna's nevus. Clin Genet 1985;27:165-6.
13. Cosman B. Experience in the argon laser therapy of port-wine stains. Plast Reconstr Surg 1980;65:119-29.
14. Mills CM, Lanigan SW, Hughes J, Anstey A. Demographic study of port wine stain patients attending a laser clinic: family history, prevalence of naves anemicus and results of prior treatment. Clin Exp Dermatol 1997;22:166-8.
15. Aelvoet GE, Jorens PG, Roelen LM. Genetic aspects of the Klippel-Trenaunay syndrome. Br J Dermatol 1992;126:603-7.
16. Ceballos-Quintal JM, Pinto-Escalante D, Castillo-Zapata I. A new case of Klippel-Trenaunay-Weber (KTW) syndrome: evidence of autosomal dominant inheritance. Am J Med Genet 1996;63:426-7.
17. Blei F, Walter J, Orlow SJ, Marchuk DA. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998;134:718-22.
18. Leblanc R, Melanson D, Wilkinson R. Hereditary neurocutaneous angiomatosis. J Neurosurg 1996;85:1135-42.
19. Iqbal A, Cormack GC, Scerri G. Hereditary multiple glomangiomas. Br J Plast Surg 1998;51:32-7.
20. van der Horst CMAM, Koster PHL, de Borgie AJM, Bossuyt P, van Gemert MJC. Effect of timing of treatment of port-wine stains with the flash-lamp-pumped pulsed dye laser. N Engl J Med 1998;338:1028-33.
21. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-22.
22. Rosen S, Smoller BR. Port-wine stains: a new hypothesis. J Am Acad Dermatol 1987;17:164-6.
23. Schneider BV, Mitsuhashi Y, Schnyder UW. Ultrastructural observations in port wine stains. Arch Dermatol Res 1988;280:338-45.
24. Finley JL, Clark RAF, Colvin RB. Immunofluorescent staining with antibodies to factor VIII, fibronectin, and collagenous basement membrane protein in normal skin and port wine stains. Arch Dermatol 1982;118:971-5.
25. Folkman J, D'Amore PA. Blood vessel formation: What is the molecular basis? Cell 1996;37:153-5.
26. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE et al. Endoglin, a TFG-beta binding protein of endothelial cells, is the gene for hereditary hemorrhagic teleangiectasia type 1. Nat Genet 1994;8:345-51.
27. Pece N, Vera S, Cymerman U, White RI, Wrana JL, Letarte M. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 1997;100:2568-79.
28. Boon LM, Mulliken JB, Vikkula M, Watkins H, Seldman J, Olsen BR et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 1994;3:1583-7.
29. Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181-90.
30. Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Hembold EA et al. A gene for familial venous malformations maps to chromosome 9p in second large kindred. J Med Genet 1995;32:197-9.
31. Dubovsky J, Zabramski JM, Kurth J. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet 1995;4:453-8.